Products/Services Used | Details | Operation |
---|---|---|
Synthetic sgRNA and crRNA Service> | Two mutations (CD44-mut1 starting at base 364 and CD44-mut2 starting at base 753) were introduced into the miR-138 binding sites by replacing adenines and guanosines within the seed sequences to cytosines using site-directed mutagenesis (GenScript, USA) | Get A Quote |
Tumor suppressive microRNAs (miRNAs) are increasingly implicated in the development of anti-tumor therapy by reprogramming gene network that are aberrantly regulated in cancer cells. This study aimed to determine the therapeutic potential of putative tumor suppressive miRNA, miR-138, against glioblastoma (GBM). Whole transcriptome and miRNA expression profiling analyses on human GBM patient tissues identified miR-138 as one of the significantly downregulated miRNAs with an inverse correlation with CD44 expression. Transient overexpression of miR-138 in GBM cells inhibited cell proliferation, cell cycle, migration, and wound healing capability. We unveiled that miR-138 negatively regulates the expression of CD44... More